Palvella Therapeutics Insider Trades

PVLA

Track insider trading activity from Palvella Therapeutics executives and directors. See which insiders are buying and selling PVLA stock.

Trades Last 12 Months

PVLA Price

All Insider Trades for Palvella Therapeutics

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Goin Kathleen Chief Operating Officer
Holding Value $497k 4,302 shares
Last Trade
May 20, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$497k 4,302 shares
$115.50
$115.42
Doux John Director
Holding Value $693k 6,000 shares
Last Trade
Apr 13, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$774k 6,000 shares
$129.00
$115.42
Jenkins George M Director
Holding Value $21.7M 187,616 shares
Last Trade
Mar 30, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$50k 445 shares
$112.30
$115.42
Heron Elaine J Director
Holding Value $5.52M 47,812 shares
Last Trade
Feb 27, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$300k 2,400 shares
$125.00
$115.42
Kline Ashley Hartmann Chief Commercial Officer
Holding Value $4.45M 38,517 shares
Last Trade
Feb 05, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.94M 38,517 shares
$76.43
$115.42
Martini Jeffrey S Chief Scientific Officer
Holding Value $7.42M 64,318 shares
Last Trade
Feb 05, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.92M 64,318 shares
$76.43
$115.42
Kaupinen Wes 10% owner, President And CEO
Holding Value $14.4M 124,603 shares
Last Trade
Feb 05, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$9.52M 124,603 shares
$76.43
$115.42
Korenberg Matthew E Cfo, Treasurer
Holding Value $5.09M 44,123 shares
Last Trade
Feb 05, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.37M 44,123 shares
$76.43
$115.42
Wessel Tadd S. Director
Holding Value $1.43M 12,350 shares
Last Trade
Jun 10, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$324k 12,350 shares
$26.23
$115.42
Holding Value $1.43M 12,350 shares
Last Trade
Jun 10, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$324k 12,350 shares
$26.23
$115.42
Davis Todd C Director
Holding Value $1.43M 12,350 shares
Last Trade
Jun 10, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$324k 12,350 shares
$26.23
$115.42
Palvella Therapeutics, Inc. Chief Scientific Officer
Holding Value $14.3M 123,559 shares
Last Trade
Feb 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$115.42

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up